Expressive

rs12300865 - LINC02882

Magnitude 4.5 · 1 study on file

Reported associations

  • Genetic association study identifies genetic variants for non-alcoholic fatty liver without comorbidities in the Korean population. - Genes & genomics (2023) · Kim YJ, Cho YS · PubMed 37133724

    Non-alcoholic fatty liver (NAFL) refers to a disease in which fat builds up in the liver, similar to what occurs for those who drink a lot of alcohol, even in cases of not drinking alcohol at all or only in a small amount. Along with non-alcoholic steatohepatitis (NASH), NAFL is a type of non-alcoholic fatty liver disease (NAFLD). Currently, the prevalence of NAFLD is increasing worldwide. A wide range of comorbidities that can increase the risk of NAFLD includes obesity, type 2 diabetes, dyslipidemia, and metabolic syndrome. This study aimed to discover genetic variants for NAFL in the Korean population. Differing from previous studies, we conducted a genome-wide association study for NAFL in the selected subjects without comorbidities to rule out bias due to the inclusion of confounding

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Bloodwork

  • Liver function tests Moderate

    Elevated aminotransferases (ALT, AST) and elevated GGT indicate hepatic inflammation and damage; regular monitoring enables early disease detection

    Baseline serum ALT, AST, GGT, total bilirubin; repeat annually or per clinician guidance

Diet

  • Refined carbohydrates and added sugars Moderate

    Simple sugars and refined carbs promote hepatic steatosis and insulin resistance; particularly important in genetic NAFLD predisposition

    Limit added sugars to <25g/day (women) or <36g/day (men); choose whole grains over refined

Discuss with your doctor

  • Liver disease risk and screening strategy Moderate

    This genetic variant is associated with substantial increased NAFLD risk; personalized screening strategy and risk modification should be discussed

    Schedule appointment with primary care physician or hepatologist to discuss genetic predisposition and screening plan

Exercise

  • Aerobic exercise Moderate

    Regular aerobic activity reduces hepatic fat content and improves insulin sensitivity; foundational for NAFLD prevention in genetically at-risk individuals

    150 minutes moderate-intensity aerobic activity per week (or equivalent high-intensity interval training)

Lifestyle

  • Alcohol Moderate

    Ethanol induces additional hepatocyte damage and fibrosis risk; complete abstinence or strict moderation recommended given genetic NAFLD predisposition

    Avoid alcohol, or limit to <1 standard drink per day if any consumption

Screening

  • Liver disease screening for NAFLD Moderate

    This genetic variant increases nonalcoholic fatty liver disease risk 2.36-fold; regular screening enables early detection and prevents progression to cirrhosis.

    Baseline liver ultrasound and serum aminotransferases; repeat ultrasound every 2 years or as clinically indicated